$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2023 Q4 Form 10-Q Financial Statement

#000141057823002550 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $4.655M $3.717M
YoY Change -19.17% -36.53%
Cost Of Revenue $3.153M $2.409M
YoY Change -22.35% -43.91%
Gross Profit $1.502M $1.308M
YoY Change -11.56% -16.23%
Gross Profit Margin 32.26% 35.19%
Selling, General & Admin $1.311M $1.334M
YoY Change 11.23% 12.2%
% of Gross Profit 87.28% 102.0%
Research & Development $77.30K $130.0K
YoY Change -23.97% 25.91%
% of Gross Profit 5.15% 9.94%
Depreciation & Amortization $9.430K $0.00
YoY Change 96.87% -100.0%
% of Gross Profit 0.63% 0.0%
Operating Expenses $1.311M $1.334M
YoY Change 2.4% 3.24%
Operating Profit $113.7K -$157.6K
YoY Change -72.79% -158.56%
Interest Expense $36.31K $33.51K
YoY Change -52.69% -51.1%
% of Operating Profit 31.92%
Other Income/Expense, Net
YoY Change
Pretax Income $102.2K -$191.1K
YoY Change -70.06% -195.26%
Income Tax -$4.672K
% Of Pretax Income
Net Earnings $102.2K -$186.4K
YoY Change -70.06% -192.93%
Net Earnings / Revenue 2.19% -5.01%
Basic Earnings Per Share $0.04 -$0.08
Diluted Earnings Per Share $0.04 -$0.08
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M
Diluted Shares Outstanding 2.313M 2.313M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.18K $250.0K
YoY Change -80.43% 39.76%
Cash & Equivalents $39.18K $254.8K
Short-Term Investments
Other Short-Term Assets $399.3K $370.0K
YoY Change 27.46% 12.74%
Inventory $4.881M $4.968M
Prepaid Expenses $399.3K $365.6K
Receivables $646.9K $822.0K
Other Receivables $2.706M $2.310M
Total Short-Term Assets $8.672M $8.719M
YoY Change -3.02% -21.06%
LONG-TERM ASSETS
Property, Plant & Equipment $199.4K $242.5K
YoY Change -44.36% -39.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $231.8K $276.0K
YoY Change -41.94% -37.28%
TOTAL ASSETS
Total Short-Term Assets $8.672M $8.719M
Total Long-Term Assets $231.8K $276.0K
Total Assets $8.904M $8.995M
YoY Change -4.69% -21.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.361M $1.990M
YoY Change 117.72% 4.96%
Accrued Expenses $410.9K $660.0K
YoY Change 19.73% 21.89%
Deferred Revenue
YoY Change
Short-Term Debt $1.121M $910.0K
YoY Change -57.74% -72.9%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.411M $3.565M
YoY Change -15.93% -45.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $53.29K $90.00K
YoY Change -74.64% -63.71%
Total Long-Term Liabilities $53.29K $93.07K
YoY Change -74.64% -62.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.411M $3.565M
Total Long-Term Liabilities $53.29K $93.07K
Total Liabilities $3.464M $3.658M
YoY Change -18.82% -45.83%
SHAREHOLDERS EQUITY
Retained Earnings -$7.469M -$7.571M
YoY Change -4.67% -7.4%
Common Stock $12.91M $12.91M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.440M $5.338M
YoY Change
Total Liabilities & Shareholders Equity $8.904M $8.995M
YoY Change -4.69% -21.68%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $102.2K -$186.4K
YoY Change -70.06% -192.93%
Depreciation, Depletion And Amortization $9.430K $0.00
YoY Change 96.87% -100.0%
Cash From Operating Activities -$424.0K $470.0K
YoY Change -158.4% 156.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 211.7K -460.0K
YoY Change -130.04% 76.54%
NET CHANGE
Cash From Operating Activities -424.0K 470.0K
Cash From Investing Activities
Cash From Financing Activities 211.7K -460.0K
Net Change In Cash -212.3K 10.00K
YoY Change -1097.79% -112.99%
FREE CASH FLOW
Cash From Operating Activities -$424.0K $470.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31747
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
363-3000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
UUU
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254818
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151502
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157012
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157012
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
821996
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
414689
CY2023Q3 uuu Account Receivables Other
AccountReceivablesOther
301838
CY2023Q1 uuu Account Receivables Other
AccountReceivablesOther
305889
CY2023Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1123834
CY2023Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
720578
CY2023Q3 uuu Due From Factor
DueFromFactor
2006624
CY2023Q1 uuu Due From Factor
DueFromFactor
2944370
CY2023Q3 us-gaap Inventory Net
InventoryNet
4968433
CY2023Q1 us-gaap Inventory Net
InventoryNet
4063632
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
365630
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
165378
CY2023Q3 us-gaap Assets Current
AssetsCurrent
8719339
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8045460
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33537
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35773
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242506
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
318641
CY2023Q3 us-gaap Assets
Assets
8995382
CY2023Q1 us-gaap Assets
Assets
8399874
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
912147
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1459350
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
154969
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
151230
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1990116
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
293465
CY2023Q1 uuu Accounts Payable To Related Parties Current
AccountsPayableToRelatedPartiesCurrent
655000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
120537
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125415
CY2023Q3 uuu Commissions And Other
CommissionsAndOther
387026
CY2023Q1 uuu Commissions And Other
CommissionsAndOther
184525
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3564795
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2868985
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
93065
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172072
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
93065
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
172072
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
23129
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7571448
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7550153
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5337522
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5358817
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8995382
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8399874
CY2023Q3 us-gaap Revenues
Revenues
3717455
CY2022Q3 us-gaap Revenues
Revenues
5857141
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2409277
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4295526
CY2023Q3 us-gaap Gross Profit
GrossProfit
1308178
CY2022Q3 us-gaap Gross Profit
GrossProfit
1561615
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1334351
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1189243
CY2023Q3 uuu Engineering And Product Development Expense
EngineeringAndProductDevelopmentExpense
131415
CY2022Q3 uuu Engineering And Product Development Expense
EngineeringAndProductDevelopmentExpense
103245
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-157588
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
269127
CY2023Q3 us-gaap Interest Expense
InterestExpense
33509
CY2022Q3 us-gaap Interest Expense
InterestExpense
68525
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-191097
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
200602
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4672
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-186425
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
200602
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
us-gaap Revenues
Revenues
10416226
us-gaap Revenues
Revenues
10492445
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7399848
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7509607
us-gaap Gross Profit
GrossProfit
3016378
us-gaap Gross Profit
GrossProfit
2982838
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2757290
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2571846
uuu Engineering And Product Development Expense
EngineeringAndProductDevelopmentExpense
196378
uuu Engineering And Product Development Expense
EngineeringAndProductDevelopmentExpense
192507
us-gaap Operating Income Loss
OperatingIncomeLoss
62710
us-gaap Operating Income Loss
OperatingIncomeLoss
218485
us-gaap Interest Expense
InterestExpense
84005
us-gaap Interest Expense
InterestExpense
124021
us-gaap Net Income Loss
NetIncomeLoss
-21295
us-gaap Net Income Loss
NetIncomeLoss
94464
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5358817
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
165130
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5523947
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-186425
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5337522
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-106138
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4532268
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
200602
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4732870
us-gaap Profit Loss
ProfitLoss
-21295
us-gaap Profit Loss
ProfitLoss
94464
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3102
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10063
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-534490
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1276912
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
1105053
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
-970998
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1239275
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-177454
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
650519
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-378841
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-547203
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
718984
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-547203
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118984
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103316
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-259857
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151502
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438735
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
254818
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
178878
us-gaap Interest Paid Net
InterestPaidNet
84005
us-gaap Interest Paid Net
InterestPaidNet
124021
CY2015 uuu Percentage Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.80
CY2015 uuu Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
1
CY2015 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2015Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
500000
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
912000
CY2023Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
899000
CY2022Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
135000
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.02
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1050
CY2023Q3 us-gaap Revenues
Revenues
3717455
CY2022Q3 us-gaap Revenues
Revenues
5857141
us-gaap Revenues
Revenues
10416226
us-gaap Revenues
Revenues
10492445
CY2023Q3 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
376000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
701000
CY2022Q3 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
353000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
990000
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
167435
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
217066
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
167000
uuu Allowance Related To Amounts Due From Factor
AllowanceRelatedToAmountsDueFromFactor
0
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
CY2023Q3 uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
us-gaap Operating Lease Expense
OperatingLeaseExpense
15000
uuu Operating Lease Rent Increment Percentage
OperatingLeaseRentIncrementPercentage
0.030
us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
uuu Adoption Of Lease Expenses Increased
AdoptionOfLeaseExpensesIncreased
468000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
233645
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
248034
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
us-gaap Operating Lease Payments
OperatingLeasePayments
77945
us-gaap Operating Lease Cost
OperatingLeaseCost
75268
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
77945
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
160567
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13381
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
251893
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3859
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
248034
CY2023Q1 uuu Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
154969
CY2023Q1 uuu Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
93065

Files In Submission

Name View Source Status
0001410578-23-002550-index-headers.html Edgar Link pending
0001410578-23-002550-index.html Edgar Link pending
0001410578-23-002550.txt Edgar Link pending
0001410578-23-002550-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20230930.xsd Edgar Link pending
uuu-20230930x10q.htm Edgar Link pending
uuu-20230930xex31d1.htm Edgar Link pending
uuu-20230930xex31d2.htm Edgar Link pending
uuu-20230930xex32d1.htm Edgar Link pending
uuu-20230930xex99d1.htm Edgar Link pending
uuu-20230930xex99d1001.jpg Edgar Link pending
uuu-20230930xex99d1002.jpg Edgar Link pending
uuu-20230930_def.xml Edgar Link unprocessable
uuu-20230930_cal.xml Edgar Link unprocessable
uuu-20230930_lab.xml Edgar Link unprocessable
uuu-20230930_pre.xml Edgar Link unprocessable
uuu-20230930x10q_htm.xml Edgar Link completed